By Phase

Preclinical

Your Partner for Preclinical Research and Development with One-Stop Platform and Solutions

Take Your Preclinical Research to the Next Level

We are committed to providing integrated, science-driven, product development services throughout the drug discovery and development process to enable life science innovation. Using state-of-the-art technologies, a global network of facilities, and a “Two Countries, One System” approach, we move customers’ research project to the next level and ensure that all testing meets worldwide standards for quality and compliance.

  • Operating in China and US with synchronized SOPs and quality standards.
  • Over 200Km2 of lab space globally, offering services ranging from drug discovery to IND-enabling packages
  • Strong track record of successful regulatory inspections by the US FDA, NMPA, WHO and US EPA, etc.
  • Extensive experience in GMP, GLP, GCP
  • AAALAC accredited animal facilities

Explore Our Preclinical Service Portfolio

Global employees
2,200+
China employees
1,000+
FDA inspections
200+
150+
NMPA inspections
200+
NDA approvals
1,000+
CMC/CDMO projects
Compounds
30,000+
Non-clinical studies
10,000+
IND applications
500+
Early clinical studies
250+

Early Phase Drug Discovery Platform

Medicinal Chemistry

  • Drug Molecular Design
  • Hit to lead
  • Quality Research
  • Customized Synthesis

Drug Screening

  • Enzymatic assays
  • Cell based assays
  • Recombinant cell line assays
  • Early MOA
  • Customized Assay validation

DMPK

  • In vitro plasma protein binding screening
  • In vitro metabolic stability
  • In vitro transporter studies
  • in vitro metabolic enzymes Studies
  • Metabolic soft spot analysis
  • In vivo pharmacokinetic screening

IND Enabling Platform

Laboratories in US, China and Europe

Quality, Scientific Integrity, Regulatory Compliance

Get in Contact

Please complete the form below to submit your request or questions. Our representative will respond promptly